The Valley Desk

ArticleCancersPublished

Prognostic Impact of Adjuvant Immunotherapy in Patients with High-Risk Upper Tract Urothelial Cancer: Results from the ROBUUST 2.0 Collaborative Group

13 of 39 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Cancers
Published
Subject terms
Immunotherapy; Outcomes; Nephroureterectomy; Upper Tract Urothelial Carcinoma
PubMed ID
40647441
PubMed Central ID
PMC12248873
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal